文献速递主动脉疾病

急性B型主动脉夹层抗冲动治疗依从性的预测因素

Predictors of Adherence to Anti-Impulse Therapy among Patients Treated for Acute Type-B Aortic Dissections.
PubMed 文献 · Ann Vasc Surg · 2021-05-02

本研究利用Truven MarketScan数据库分析2008至2017年美国急性B型主动脉夹层患者,评估抗冲动治疗依从性及其预测因素。共纳入6702例患者,总体平均依从率为72.6%,女性、年龄<45岁、既往依从性差及零售药房取药供应不足90天的患者依从性显著更低,而邮寄取药和处方供应>90天者依从性改善。

要点

  • 急性TBAD后近四分之一患者对抗冲动治疗不依从。
  • 女性、<45岁、既往不依从及零售药房取药<90天供应者依从性更低。
  • 邮寄取药和>90天供应处方与依从性改善相关。

核心结论

  • 急性B型主动脉夹层后抗冲动治疗不依从率约四分之一,年轻女性及事件前即不依从者风险更高。

研究设计与样本

  • 基于Truven MarketScan数据库的回顾性队列研究,纳入2008至2017年美国急性TBAD且连续保险≥12个月的患者6702例。

主要发现

  • 总体平均依从率为72.6%±26,TEVAR组73.4%、OPEN组74.4%、MED组72.4%。
  • 女性依从性 odds 显著更低(OR 0.93;95%CI 0.85-0.99;P=0.03)。
  • 年龄<45岁依从性 odds 显著更低(OR 0.81;95%CI 0.69-0.96;P<0.001)。
  • 既往治疗不依从者依从性 odds 显著更低(OR 0.81;95%CI 0.73-0.89;P<0.001)。
  • 零售药房取药供应<90天者依从性更低;邮寄取药和>90天供应处方者依从性改善。

关键数值与推荐

  • 依从性定义为随访期间药物持有率>80%的填充率。
  • 多数患者处方≥2种药物,β受体阻滞剂和利尿剂最常见。

临床怎么用

  • 对急性TBAD出院患者应关注抗冲动治疗依从性,尤其年轻女性及既往不依从者。
  • 可考虑邮寄取药和开具>90天供应处方以改善依从性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Medical management remains the mainstay of treatment for patients who present with acute Type-B aortic dissections (TBAD). However, it is unclear whether patients maintain adherence to their anti-impulse therapy medication regimen following hospital discharge. This study was designed to evaluate rates and predictors of medication adherence among insured patients treated for acute TBAD. METHODS: We used the Truven MarketScan database to identify US patients who presented with an acute TBAD between 2008 to 2017. Patients with continuous health insurance (Commercial or Medicare Part C) for at least 12 months after TBAD diagnosis were stratified by whether they underwent open surgical repair (OPEN), thoracic endovascular aortic repair (TEVAR), or only medication management (MED). Prescriptions for anti-impulse therapy medications were captured and adherence was defined by the medication possession ratio as > 80% fill rate over the follow-up period. Mixed-effects logistic regression models were used to identify predictors for medication adherence. RESULTS: A total of 6,702 patients were identified that underwent treatment for TBAD (3% TEVAR, 9% OPEN, & 74% MED), whereas 14% received no intervention. The overall mean (±SD) rate of adherence to anti-impulse therapy was 72.6% ( ± 26), and varied based on type of TBAD intervention (73.4% TEVAR, 74.4% OPEN, & 72.4% MED). The majority of patients across all treatment groups were prescribed ≥ 2 agents, with beta-blockers and diuretics being the most common medication classes. The odds of adherence to anti-impulse therapy were significantly lower for patients who were female (OR: 0.93; 95%CI:0.85-0.99; P = 0.03), aged < 45 years (OR: 0.81; 95%CI:0.69-0.96; P < 0.001), nonadherent on preexisting therapy (OR: 0.81; 95%CI: 0.73-0.89; P < 0.001), and when medications were obtained in less than a 90 days supply from retail pharmacies. CONCLUSIONS: Nearly a quarter of patients were nonadherent with anti-impulse therapy prescribed following an acute TBAD, which was more likely among younger female patients not adherent before their event. Adherence was improved among patients who received their medications by mail and when a > 90 days supply was prescribed. These findings may be used by quality improvement initiatives to improve medication adherence following TBAD and help prevent further complications.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Brooke BS, Griffin CL, Glotzbach JP, et al. Predictors of Adherence to Anti-Impulse Therapy among Patients Treated for Acute Type-B Aortic Dissections. Ann Vasc Surg. 2021. PMID: 33951520. doi:10.1016/j.avsg.2021.04.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。